PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Clinical trials for PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME trials appear
Sign up with your email to follow new studies for PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an immune treatment ease severe OCD in kids with PANS?
Symptom relief CompletedThis study tested whether a medicine called Panzyga (given through a vein) can reduce obsessive-compulsive symptoms in children aged 6 to 17 with a condition called PANS or PANDAS. These children experience a sudden, severe onset of OCD and other neuropsychiatric problems. The st…
Matched conditions: PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Phase: PHASE3 • Sponsor: Octapharma • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Hidden costs of PANS: new study reveals financial toll of IVIG treatment
Knowledge-focused CompletedThis completed study surveyed 65 U.S. families to understand the economic and quality-of-life impact of IVIG treatment for PANS/PANDAS. Researchers asked about medical visits, insurance, work absences, and children's school attendance. The goal is to shed light on the hidden cost…
Matched conditions: PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Sponsor: Brain Inflammation Collaborative • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:31 UTC